Source:http://linkedlifedata.com/resource/pubmed/id/21544729
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-5-5
|
pubmed:abstractText |
Although Epstein-Barr virus (EBV) is associated with 6-16% of the gastric carcinoma (GC) cases, the effect of EBV infection on the tumorigenesis process and the responsiveness to chemotherapy remain unclear. We compared chemosensitivity of the EBV-positive GC (AGSEBV) and EBV-negative GC (AGS) cells to 5-fluorouracil (5-FU). Although 5-FU inhibited the growth of both cell lines in a dose- and time-dependent manner, the sensitivity of EBV-positive GC cells to 5-FU was lower than that of EBV-negative GC cells. The cleavage of PARP and caspase-3 was also lower in AGS-EBV cells than in AGS cells following 5-FU treatment. Both the level of Bcl-2 expression and the ratio of Bcl-2/Bax were higher in AGS-EBV than in AGS cells not only at basal state but also following 5-FU treatment. Moreover, p53 and p21 expression was enhanced further by 5-FU in AGS than in AGS-EBV cells. Immunofluorescence assay and Western blot showed that 5-FU induced the expression of EBV-lytic genes including BZLF1, BRLF1, BMRF1 and BHRF1. Our results suggest that latent and lytic EBV infection contributes to the chemoresistance to 5-FU in gastric carcinoma by modulating apoptosis related cellular genes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0253-6269
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
635-43
|
pubmed:meshHeading |
pubmed-meshheading:21544729-Antimetabolites, Antineoplastic,
pubmed-meshheading:21544729-Apoptosis,
pubmed-meshheading:21544729-Blotting, Western,
pubmed-meshheading:21544729-Cell Culture Techniques,
pubmed-meshheading:21544729-Cell Line, Tumor,
pubmed-meshheading:21544729-Cell Proliferation,
pubmed-meshheading:21544729-Cell Survival,
pubmed-meshheading:21544729-Dose-Response Relationship, Drug,
pubmed-meshheading:21544729-Drug Resistance, Neoplasm,
pubmed-meshheading:21544729-Epstein-Barr Virus Infections,
pubmed-meshheading:21544729-Fluorouracil,
pubmed-meshheading:21544729-Humans,
pubmed-meshheading:21544729-Neoplasm Proteins,
pubmed-meshheading:21544729-Stomach Neoplasms,
pubmed-meshheading:21544729-Time Factors
|
pubmed:year |
2011
|
pubmed:articleTitle |
Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
|
pubmed:affiliation |
Research Institute of Immunobiology, Department of Medical Lifescience, College of Medicine, Catholic University of Korea, Seoul, 137-701, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|